Q32 Bio Inc. (QTTB) FCF Margin (2018 - 2023)

Q32 Bio has reported FCF Margin for 6 years, with the latest figure at 1077.13% in Q4 2023.

• On a quarterly basis, FCF Margin rose 446965.0% year-over-year to 1077.13% in Q4 2023; TTM through Sep 2024 was 5260.15%, a 566567.0% increase from a year earlier, with the FY2025 full-year figure at 64.21%, changed N/A from the prior year.
• FCF Margin was 1077.13% for Q4 2023 at Q32 Bio, up from 835.29% in the prior quarter.
• The five-year high for FCF Margin was 1077.13% in Q4 2023, with the low at 10495.19% in Q1 2019.
• Average FCF Margin over 5 years is 3252.65%, with a median of 3614.46% recorded in 2021.
• The sharpest annual moves came in 2019 and 2020: FCF Margin tumbled 942530 bps in 2019, then surged 575386 bps in 2020.
• Over 5 years, FCF Margin stood at 5338.9% in 2019, then soared by 76 bps to 1282.35% in 2020, then slumped by 199 bps to 3836.41% in 2021, then gained by 12 bps to 3392.52% in 2022, then soared by 132 bps to 1077.13% in 2023.
• The last three FCF Margin figures came in at 1077.13% (Q4 2023), 835.29% (Q3 2023), and 357.07% (Q2 2023), per Business Quant data.